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Summary
Friedreich ataxia (FRDA), an autosomal recessive, neu-
rodegenerative disease is the most common inherited
ataxia. The vast majority of patients are homozygous
for an abnormal expansion of a polymorphic GAA trip-
let repeat in the first intron of the X25 gene, which en-
codes a mitochondrial protein, frataxin. Cellular degen-
eration in FRDA may be caused by mitochondrial
dysfunction, possibly due to abnormal iron accumula-
tion, as observed in yeast cells deficient for a frataxin
homologue. Using RNase protection assays, we have
shown that patients homozygous for the expansion have
a marked deficiency of mature X25 mRNA. The mech-
anism(s) by which the intronic GAA triplet expansion
results in this reduction of X25 mRNA is presently un-
known. No evidence was found for abnormal splicing
of the expanded intron 1. Using cloned repeat sequences
from FRDA patients, we show that the GAA repeat per
se interferes with in vitro transcription in a length-de-
pendent manner, with both prokaryotic and
eukaryotic enzymes. This interference was most pro-
nounced in the physiological orientation of transcrip-
tion, when synthesis of the GAA-rich transcript was at-
tempted. These results are consistent with the observed
negative correlation between triplet-repeat length and
the age at onset of disease. Using in vitro chemical prob-
ing strategies, we also show that the GAA triplet repeat
adopts an unusual DNA structure, demonstrated by hy-
perreactivity to osmium tetroxide, hydroxylamine, and
diethyl pyrocarbonate. These results raise the possibility
that the GAA triplet-repeat expansion may result in an
unusual yet stable DNA structure that interferes with
transcription, ultimately leading to a cellular deficiency
of frataxin.
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Introduction
Friedreich ataxia (FRDA) is the most common inherit-
ed ataxia, with an estimated prevalence of 1/50,000–
2/50,000. Clinical features include progressive gait and
limb ataxia, areflexia, loss of position sense, dysarthria,
and positive Babinski sign (Harding 1981). In addition
to the neurodegenerative phenotype, most patients have
hypertrophic cardiomyopathy, and nearly a third have
either diabetes mellitus or a lesser degree of carbohydrate
intolerance (Finocchiaro et al. 1988). Most patients de-
velop symptoms in their early teens, are wheelchair
bound by their late 20s, and usually die in their mid
30s. For a recessive disease, the range of phenotypic
severity displayed by FRDA patients is unusually broad,
including exceptionally delayed age at onset (De Michele
et al. 1994), retention of deep-tendon reflexes (Palau et
al. 1995), and atypically gradual progression of disease
seen in Acadians (Barbeau et al. 1984) and some Cau-
casians (Bidichandani et al. 1997).
The vast majority (195%) of FRDA patients are
known to be homozygous for an unstable GAA triplet-
repeat expansion in the first intron of the X25 gene,
which normally encodes a 210-amino-acid protein, fra-
taxin (Campuzano et al. 1996). FRDA is associated with
alleles bearing 66–1,700 or more GAA triplets, whereas
normal individuals have 7–38 repeats (Campuzano et
al. 1996; Du¨rr et al. 1996; Epplen et al. 1997). GAA
triplet-repeat expansions arise by hyperexpansion of
long normal alleles (Cosse´e et al. 1997b; Montermini et
al. 1997a), somewhat similar to the intergenerational
expansion of premutation alleles seen in the other triplet-
repeat diseases (Bidichandani and Patel 1996). A strong
negative correlation was demonstrated between the age
at onset and the size of the GAA triplet-repeat expansion
in the smaller of the two expanded alleles (Du¨rr et al.
1996; Filla et al. 1996; Montermini et al. 1997b). The
remaining patients are compound heterozygotes for the
expansion and another pathological mutation in theX25
gene (Campuzano et al. 1996; Filla et al. 1996; Bidi-
chandani et al. 1997; Cosse´e et al. 1997a). Most point
mutations generate null alleles, although elsewhere we
have demonstrated that the G130V missense mutation
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generates a mild loss-of-function FRDA allele associated
with an atypically mild phenotype (Bidichandani et al.
1997). No molecular explanation has been causally re-
lated to the retention of deep-tendon reflexes seen in
some patients or to the slow disease progression in Aca-
dian FRDA patients (Montermini et al. 1997b).
Frataxin is a mitochondrial protein thought to regu-
late iron homeostasis. A yeast strain deficient for a ho-
mologous protein exhibits both excess mitochondrial
iron accumulation and defective oxidative metabolism
as a result of mitochondrial dysfunction (Babcock et al.
1997). Human frataxin is likely to serve a similar func-
tion, for the following reasons: its localization to the
mitochondria, the demonstration of abnormal myocar-
dial iron deposits in FRDA patients (Lamarche et al.
1993), and the pathological involvement of postmitotic
tissues largely dependent on efficient oxidative metab-
olism (Harding 1993).
We present experiments performed in an effort to un-
derstand how the GAA triplet-repeat expansion in intron
1 of X25 leads to FRDA. Our demonstration of a severe
deficiency of X25 steady-state mRNA levels in a series
of patients homozygous for the GAA triplet-repeat ex-
pansion is consistent with the observed autosomal re-
cessive inheritance. A single patient known to carry an
expansion smaller than that seen in the average FRDA
patient was shown to have a less severe deficiency, sup-
porting the association of smaller expansions with
milder disease. Using cloned repeats within the appro-
priate context of the X25 intron 1 sequence derived from
FRDA patients, we demonstrate that the GAA repeat
produces a length- and orientation-dependent deficiency
of in vitro transcription, directed by both prokaryotic
and eukaryotic RNA polymerases under physiological
conditions. Furthermore, using chemical probes, we
demonstrate that the homopurine•homopyrimidine
(pur•pyr) sequence resulting from the GAA triplet repeat,
flanked by its natural intronic sequence, adopts an un-
usual DNA structure in vitro under physiological
conditions.
Material and Methods
Antisense Riboprobe Preparation and RNase
Protection Assay
For synthesis of antisense riboprobes, two regions of
the X25 cDNA, one containing partial sequence from
exons 1 and 2 spliced together (58 to 252 [Cam-
puzano et al. 1996]; FRDA-riboX2) and the other con-
taining partial sequence of exon 4 and complete se-
quence of exon 5b spliced together (344 to 642
[Campuzano et al. 1996]; FRDA-riboA1), were sub-
cloned into the pMOSBlue T-vector (Amersham). One
microgram of EcoRI-linearized plasmid was used as a
template for in vitro transcription using T7 RNA poly-
merase and the Ambion Maxiscript kit in a reaction
containing 3.125 mM [a-32P] UTP (Amersham). Full-
length labeled antisense transcripts were purified after
preparative denaturing PAGE. A radiolabeled human
GAPDH antisense riboprobe (pTRI-GAPDH human;
Ambion) was generated as a control. RNase protection
assays were performed by use of the RPAII Ribonuclease
protection assay kit (Ambion), according to the manu-
facturer’s recommendations. Exposure to x-ray film was
for 6 d at 70C with intensifying screens. Sizes of the
protected fragments were estimated by use of a sequence
ladder that had been coelectrophoresed.
Cloning of GAA/TTC Repeat Sequences
Individual FRDA alleles containing GAA triplet-re-
peat sequences were amplified from two patients and
from a heterozygous carrier. PCR was performed with
primers (GAA-104F and GAA-629R) to amplify the
GAA triplet repeat, including 251 bp and 248 bp of
upstream and downstream intron 1 flanking sequence,
respectively (Filla et al. 1996; GenBank accession num-
ber U43748). Both the normal allele from the hetero-
zygous carrier (9 repeats) and the smaller of the two
expansions from two patients (240 and 350 repeats)
were gel purified and directly subcloned into the pCR3.1
eukaryotic TA cloning vector (Invitrogen). In order to
minimize the chances of rearrangements mediated by the
repeat sequences, bacterial cultures (TOP10F′; Invitro-
gen) were routinely grown by orbital shaking at room
temperature. The pCR3.1 vector contains the cytomeg-
alovirus (CMV) immediate-early promoter and the T7
promoter upstream of the multiple cloning site, for eu-
karyotic and prokaryotic gene expression, respectively.
Inserts of various sizes were obtained, and, after direct
sequencing of the plasmid vectors, four TTC repeats
(reverse orientation) were selected for further analysis:
(TTC)n, where n 9, 44, 75, and 100. Minor variations
in the sequence of otherwise homogeneous TTC tracts
were seen, but these did not alter the pur•pyr nature of
the repeats. The exact sequences of the TTC tracts were
as follows: (TTC)9  (TTC)9; (TTC)44  (TTC)35
T(TTC)3TCC(TTC)5; (TTC)75  (TTC)66T(TTC)3TCC
(TTC)5; and (TTC)100  (TTC)87TCC(TTC)3T(TTC)3
TCC(TTC)5. Since all recombinants contained inserts in
the reverse orientation, the four sequenced TTC inserts
were flipped to obtain GAA inserts. This was done by
PCR amplifying each of the four TTC repeats (again
with GAA-104F and GAA-629R) and recloning them
into the pCR3.1 vector. This resulted in inserts of either
orientation. Minor changes in repeat length (with no
mutations in the flanking sequence) led to the selection
of four GAA repeats for further analysis: (GAA)n, where
n 9, 46, 79, and 100. The exact sequences of the GAA
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tracts were as follows: (GAA)9  (GAA)9; (GAA)46 
(GAA)5GGA(GAA)3A(GAA)37; (GAA)79  (GAA)5GGA
(GAA)3A(GAA)70; and (GAA)100  (GAA)5GGA(GAA)3
A(GAA)3GGA(GAA)87. Identical sequence interruptions
were seen in the otherwise pure GAA/TTC sequence of
four of five expanded TTC clones generated from the
GAA-240 allele (including two not used for experiments
in this paper), and these are distinct from those reported
by Montermini et al. (1997a). All experiments were per-
formed with the same plasmid maxipreps as were used
for sequencing.
In Vitro Transcription Experiments
In vitro transcription of GAA/TTC repeat-containing
constructs was performed with both T7 RNA polymer-
ase (MAXIscript kit; Ambion) and HeLa nuclear extract
(In Vitro Transcription system; Promega). Transcription
using T7 RNA polymerase was performed as follows:
0.1 mg of XbaI-linearized plasmid was transcribed in a
20-ml volume by use of 0.5 mM of each of the three
nonlimiting cold ribonucleotides, 10 units of T7 RNA
polymerase in a buffer supplying 6 mM MgCl2, and pH
7.5. For synthesis of the GAA-rich and UUC-rich tran-
scripts, [a-32P] rGTP and [a-32P] rCTP (Amersham) were
used at a final concentration of 2.4 mM each. Reactions
were supplemented with 25 mM cold rGTP and rCTP,
respectively, to facilitate the generation of full-length
transcript. After incubation at 37C for 1 h, DNA tem-
plates were digested by RNase-free DNase I (Ambion).
Transcription using HeLa nuclear extract (Promega)
was performed exactly according to the manufacturer’s
recommendations. In brief, 0.1 mg XbaI-linearized plas-
mid was transcribed in a 25-ml volume by use of 0.4
mM of each of the three nonlimiting cold ribonucleo-
tides, 8 units transcription-competent HeLa nuclear ex-
tract (Promega) in a buffer supplying 3 mM MgCl2, and
pH 7.9. For synthesis of the GAA-rich and UUC-rich
transcripts, [a-32P] rGTP and [a-32P] rCTP (Amersham)
were used at a final concentration of 1.0 mM each. Re-
actions were supplemented with 16 mM cold rGTP and
rCTP, respectively, to facilitate the generation of full-
length transcript. Reactions were performed at 30C for
1 h, and the products were phenol-extracted and etha-
nol-precipitated.
The expected full-length runoff transcript sizes gen-
erated with the above-listed (TTC)n and (GAA)n con-
structs, by use of T7, are 671, 776, 869, and 944 nt and
671, 779, 881, and 944 nt, respectively. For transcripts
expressed from the CMV promoter, the corresponding
sizes are 689, 794, 887, and 962 nt and 689, 797, 899,
and 962 nt, respectively. Products were denatured in
formamide and were resolved by denaturing PAGE. Den-
sitometric analysis was performed by use of the Col-
lage image-analysis software package (Fotodyne).
Densitometric readings were divided by the exact num-
ber of G’s and C’s expected in the full-length GAA-rich
and UUC-rich transcripts, respectively, to normalize the
results for the changes in transcript length (densitometric
units/nt).
Chemical Probing of Repeats
Partial X25 intron 1 sequences containing normal and
expanded GAA repeats were amplified, gel purified
(Qiaex II; Qiagen), and radiolabeled prior to chemical
analyses. The GAA repeats were flanked by 0.4 kb and
1.1 kb upstream and downstream intron 1 sequence,
respectively (Campuzano et al. 1996). Two expanded
alleles, containing 240 and 350 GAA triplets, and six
normal alleles isolated from unrelated heterozygous car-
riers were analyzed. As controls, 590 bp of the murine
Rapsyn gene and 822 bp of the Escherichia coli b-gal-
actosidase gene (Hanley and Merlie 1991) were similarly
analyzed. DNA fragments were end labeled by use of
[g-32P] ATP and either were purified by use of nucleotide-
removal columns (Qiagen) or subsequently were di-
gested with BamHI (TTC strand labeled) or SmaI (GAA
strand labeled), and gel-purified. Osmium tetroxide
(0.025% in the presence of 3% pyridine for 1–2 h at
37C; Aldrich) reactions and DEPC (1%–6% for 15 min
at 37C; Sigma) reactions were performed in TM10-7.4
buffer (10 mM Tris-HCl pH 7.4 and 10 mM MgCl2).
Osmium tetroxide reactions were also performed in five
additional buffers, at pH 7.0–8.0 (Sigma). Hydroxyla-
mine hydrochloride (2.3 M for 1–2 h at 37C; Sigma)
reactions were performed at pH 6, with diethylamine
(Sigma) in the presence of 10 mM MgCl2. Chemical
modifications were followed by cleavage with piperidine
(10% for 30 min at 90C; Sigma) and resolution of cleav-
age products on 1% denaturing agarose gels in alkaline
electrophoresis buffer (50 mN NaOH and 1 mM EDTA).
Gels were treated with 7% trichloroacetic acid prior to
drying and autoradiography.
Results
Severe Deficiency of Normally Spliced X25 mRNA in
FRDA Patients
To investigate levels of X25 mRNA in FRDA patients
homozygous for the GAA triplet-repeat expansion, we
performed RNase protection assays using two probes
targeted to different regions of the mature X25 tran-
script. Both probes, one recognizing the junction be-
tween exons 1 and 2 (FRDA-riboX2; fig. 1) and the other
recognizing exons 4 and 5b (FRDA-riboA1; data not
shown), revealed a striking reduction in steady-stateX25
mRNA levels in lymphoblasts from a series of FRDA
patients. One patient (P63) however, revealed levels sig-
nificantly greater than those seen in the other patients
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Figure 1 RNase protection assay of mature X25 transcript,
showing a marked deficiency in FRDA patients. RNase protection
assays were performed by use of FRDA-riboX2 (a) and a control
human GAPDH riboprobe (b). Total lymphoblast RNA from control
individuals (unblackened circles), patients (blackened symbols), and a
single carrier (half-blackened circle) were analyzed as indicated above
the respective lanes. YR indicates the use of yeast RNA as a control.
The FRDA-riboX2 probe detected a single protected fragment of 273
nt, corresponding to the spliced product of exons 1 and 2 (for exact
cDNA positions, see Material and Methods). Except for P63, who
showed a less severe deficiency of residual transcript, all FRDA patients
show a marked reduction of mature X25 mRNA. No other protected
bands were visible.
tested in the same experiment (fig. 1). Assessment of the
length of GAA repeat expansion by long-range PCR
(Campuzano et al. 1996) revealed that all patients except
P63 had 500–950 repeats in both their FRDA alleles.
Patient P63 carried one expanded allele that was in the
same size range as that seen in the other patients (530
triplets), whereas his other allele had a much smaller
expansion, containing 240 repeats.
In addition to mRNA quantitation, the riboprobe
FRDA-riboX2 was specifically designed to investigate
the splicing status of intron 1. If the abnormally ex-
panded intron 1 were to be misspliced, individual exon
1–only and exon 2–only protected fragments would be
expected. However, only the normally spliced product
of exons 1 and 2 was detected, indicating that the ab-
normal expansion of intron 1 in FRDA does not sig-
nificantly interfere with X25 mRNA processing. It
should be noted that this is not a formal exclusion of
missplicing, since it is possible for the anomalously
spliced isoform(s) to be unstable and therefore unde-
tectable in this assay.
Prokaryotic and Eukaryotic In Vitro Transcription of
GAA Triplet Repeats: Length- and Orientation-
Dependent Deficiency
Using PCR products generated from FRDA patients
and normal controls, we were able to clone four lengths
each of (GAA)n (n  9, 45, 79, and 100) and (TTC)n
(n  9, 44, 75, and 100) repeats into a suitable ex-
pression vector that would allow in vitro transcription
using both prokaryotic (T7) and eukaryotic (CMV im-
mediate early) promoters (fig. 2A). The exact sequence
of these repeats were determined by direct sequencing
of the plasmid vectors (see Material and Methods). In
addition to the actual triplet-repeat sequence, these in-
serts also contain ∼250 bp of intron 1 flanking sequence
on either side, creating a natural sequence context as
compared with the analysis of pure synthetic trinucle-
otide-repeat elements. Using these constructs, we sought
to investigate the relative efficiencies of transcription of
various lengths of GAA and TTC triplet repeats, in an
attempt to determine whether the GAA expansion posed
a particular hindrance.
Figure 2A shows a diagrammatic representation of the
repeat-containing constructs and the two promoters
used, as well as the site of linearization permitting runoff
in vitro transcription. As seen in figure 2B and C, a
deficiency was seen in the transcription of expanded
GAA repeats, by use of both the prokaryotic T7 pro-
moter and the eukaryotic CMV promoter. It is important
to note that these assays involve the incorporation of
radiolabeled rNTPs and that the increase in length of
the transcript therefore results in an underestimation of
the actual deficiency. Normalization for the changes in
transcript length was therefore performed (see Material
and Methods) and was used to plot the graphs in figure
2B and C. These transcription experiments were per-
formed twice, on two independent occasions, yielding
identical results.
There were four significant features displayed by the
observed transcriptional deficiency. First, it was observed
at physiological pH and magnesium-ion concentration.
Second, it was length dependent, becoming significant
only after a threshold was reached—that is, when the
two larger GAA repeat lengths (79 and 100) were tran-
scribed. Third, the effect on transcription was orienta-
tion specific, wherein the synthesis of GAA-rich
transcript—that is, the physiological direction of tran-
scription—was clearly more severely affected. Synthesis
of UUC-rich mRNA was either relatively unchanged (fig.
2C) or more mildly affected (fig. 2B) over the lengths
used in these experiments. Minor variation in the profiles
of transcription deficiency observed in figure 2B and C
possibly reflect the differing dynamics of the prokaryotic
and eukaryotic systems used. The increase in band in-
tensity seen with synthesis of longer UUC RNA by use
of HeLa nuclear extract (fig. 2C) most likely reflects the
increased incorporation of radiolabel, because of in-
crease in transcript length, which is not seen after nor-
malization. Fourth, the reduction in transcription was
observed with use of linear templates and is therefore
independent of DNA template superhelicity. Taken to-
gether, these results are consistent with the observed
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Figure 2 Expansion of GAA triplet repeat interfering with transcription. A, Diagrammatic representation of recombinant constructs
containing GAA/TTC triplet repeats (not drawn to scale). A partial sequence of X25 intron 1 (hatched boxes) is shown containing n copies of
either the GAA (correct orientation) triplet repeat or the TTC (reverse orientation) triplet repeat. Intron 1 sequences were amplified by PCR
primers (arrowheads) and inserted in the TA-cloning site of pCR3.1 (Invitrogen). The CMV immediate early promoter (pCMV) and the T7
promoters are indicated by large and small arrows, respectively. Plasmids were linearized at the unique XbaI site, to permit runoff in vitro
transcription. For the exact sequence of repeats and PCR primers used, see Material and Methods. B, In vitro transcription using T7 RNA
polymerase and the indicated GAA/TTC repeat–bearing constructs as templates. Products of transcription were resolved by denaturing PAGE
and relative band intensities analyzed by densitometry. Densitometric readings were normalized for length of the full-length transcript and were
plotted as densitometric units/nucleotide. A marked reduction is seen in the accumulation of full-length transcript when the GAA repeat length
is increased from 46 to 79 triplets. A less severe reduction is seen with comparable increases in TTC repeat length. C, In vitro transcription
using HeLa nuclear extract and the indicated GAA/TTC repeat–bearing constructs as templates. Products of transcription were resolved and
analyzed as in B. A marked reduction is seen in the accumulation of full-length transcript when the GAA repeat length is increased from 46
to 100 triplets. No reduction is seen with comparable increases in TTC repeat length. The increase in band intensities seen with longer TTC
clones is thought to reflect the length-dependent increase in incorporation of radiolabel, since this was not seen after normalization. Truncated
transcripts were not detected.
length-dependent deficiency of normally spliced mature
X25 mRNA in FRDA patients’ lymphoblasts.
The GAA Triplet Repeat within Its Natural Flanking
Intronic Sequence: Adoption of an Unusual DNA
Structure In Vitro
Pur•pyr sequences such as the GAA triplet repeat are
known to form intramolecular triplexes in supercoiled
plasmids (see Discussion). However, since reduced syn-
thesis of the GAA-rich mRNA was observed after tran-
scription of linearized DNA templates, we sought to in-
vestigate whether the GAA repeat adopts an unusual
DNA structure without a source of supercoiling. With
osmium tetroxide, hydroxylamine, and DEPC used as
chemical probes for the detection of such unusual DNA
structures, linear DNA molecules representing normal
and expanded alleles, each flanked by intron 1 sequence
(∼0.4 kb upstream and ∼1.1 kb downstream of the GAA
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repeat sequence, respectively), were assayed in the pres-
ence of physiological pH and cationic conditions.
The above-mentioned chemical probes have been
widely used for the detection and finer characterization
of unusual DNA structures, including intramolecular
DNA triplexes, left-handed Z DNA, and cruciforms,
where they detect unpaired regions or regions of altered
DNA conformation (Wells et al. 1988). Neither chemical
is found to modify regular right-handed B DNA, al-
though their reactivity with specific bases is significantly
enhanced if unpaired or altered in conformation; os-
mium tetroxide reacts with pyrimidines (mainly thy-
mine), hydroxylamine with cytosines, and DEPC with
purines (adenine 1 guanine). The chemically modified
bases are then readily detected after cleavage with pi-
peridine, as in standard Maxam-Gilbert sequencing re-
actions. Most investigators resolve their reaction prod-
ucts on sequencing gels, to determine exact base
positions of the hyperreactive sites. In our experiments,
we used relatively long DNA repeat sequences (1.5–3.0-
kb fragments containing 9–350 GAA repeats), and there-
fore resolution was performed on denaturing (alkaline)
agarose gels, resulting in thicker or fuzzier cleavage
bands (possibly representing a collection of bands dif-
fering only slightly in length), allowing only approxi-
mate mapping of hyperreactive sites.
As seen in figure 3A, the normal, (GAA)9, and the
expanded (GAA)240, DNA molecules show cleavage after
being probed with osmium tetroxide and DEPC, indi-
cating that the DNA in this region adopts a non–B DNA
structure. Another expanded allele, consisting of 350
GAA repeats, and five additional alleles with normal
repeat lengths, isolated from unrelated heterozygous car-
riers, were also shown to be similarly hyperreactive by
use of these chemical probes (data not shown). Probing
of the (GAA)9 repeat with hydroxylamine produced the
same cleavage pattern as was seen with osmium tetrox-
ide (fig. 3B). The single cleavage product seen with os-
mium tetroxide and with hydroxylamine and the smaller
of the two products seen with DEPC mapped to the
homopyrimidine and homopurine strands of the GAA
sequence, respectively. Identical analyses with unrelated
control sequences, originating from the murine Rapsyn
gene and from the E. coli b-galactosidase gene, did not
reveal any hyperreactive sites (data not shown).
A 38-bp A-rich sequence, (A)6(TAA)4AT(A)5T(A)6
T(A)4T, was revealed on examination of the flanking
intronic sequence in the region of the second (larger)
DEPC cleavage product (located ∼150 bp 3′ of the GAA
repeat; GenBank accession number U43748). For better
localization of the observed hyperreactive sites and for
confirmation of the location of the larger DEPC cleavage
product, portions of the flanking intronic sequence were
removed by digestion with restriction enzymes prior to
chemical probing (see Material and Methods). As seen
in figure 3C, the osmium tetroxide hyperreactive site
mapped to the homopyrimidine strand of the GAA re-
peat. Prior to being probed with DEPC, the radiolabeled
DNA template was cleaved at the unique SmaI site, sep-
arating the GAA repeat from the A-rich sequence (fig.
3F), and the DNA fragment containing the former (pu-
rine strand labeled) was gel purified. This time only one
DEPC cleavage product was generated (with use of two
different concentrations of DEPC), which mapped to the
homopurine strand of the GAA repeat (fig. 3D). Signif-
icantly, the pyrimidine-specific and purine-specific chem-
ical probes did not react with bases on the opposite
strands (fig. 3C and D). Hyperreactivity to chemical
probes was tested and detected at pH 6.0–8.0. Hydrox-
ylamine treatment was performed at pH 6.0 (see Ma-
terial and Methods), which showed a cleavage pattern
identical to that seen with osmium tetroxide in buffers
at pH 7.0–8.0 (fig. 3B and E).
As mentioned above, it was not possible to map the
exact base locations of the hyperreactive sites within the
GAA repeat. However, the well-known base specificities
of the chemical probes allow us to surmise that osmium
tetroxide, hydroxylamine, and DEPC detected unpaired
T’s, C’s, and A’s in the respective complementary strands
of the GAA repeat sequence (Wells et al. 1988). These
results (summarized in fig. 3F) indicate that the region
of the GAA repeat (flanked by the natural intron 1 se-
quence) adopts an unusual, non–B DNA structure in the
absence of any source of supercoiling under physiolog-
ical conditions (see Discussion). Although these results
are consistent with the formation of an intramolecular
DNA triplex, the approximations involved in our ex-
periments do not permit such a conclusive determina-
tion. Consequently, these results are also consistent with
other unusual structures, such as slipped DNA (Pearson
and Sinden 1996), heteronomous DNA (Evans and Ef-
stratiadis 1986), and distortions of duplex DNA that are
seen at duplex-triplex junctions flanking intermolecular
DNA triplexes (Hartman et al. 1992). It is, however, not
consistent with the J DNA conformation observed with
the (GA)18 sequence at mildly alkaline pH (Htun and
Dahlberg 1988).
Discussion
We have shown that FRDA patients homozygous for
the GAA expansion have a severe deficiency of mature
X25 mRNA, with no evidence of abnormal splicing of
the expanded intron 1. This is expected to lead to a
deficiency of frataxin, and affected tissues could suffer
the same mitochondrial dysfunction seen in yeast strains
deficient in a frataxin homologue (Babcock et al. 1997).
We have also shown, under physiological conditions,
that the GAA repeat results in a length-dependent de-
ficiency of transcription in vitro, using both prokaryotic
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Figure 3 Adoption of an unusual DNA structure in vitro by the GAA triplet repeat within X25 intron 1. Chemical probing of the (GAA)9
repeat is shown in A–E, and that of the (GAA)240 repeat is shown in A. DNA sequences were analyzed with both strands labeled (A, B, and
E) and with either the pyrimidine-rich (BamHI-cleaved [C]) or the purine-rich (SmaI-cleaved [D]) strands labeled. The repeats were analyzed
within the natural context of their flanking X25 intron 1 sequence. Reaction products were resolved on denaturing (alkaline) agarose gels.
Chemical treatment was performed with osmium tetroxide (Os), hydroxylamine (Hy), and DEPC (DEP). “DEP-1” and “DEP-6” denote samples
treated with 1% DEPC and 6% DEPC, respectively. UT and PIP refer to untreated DNA molecules and to molecules treated with piperidine
without any prior chemical modification, respectively. In E, the numbers (7–8) indicate the pH of the reaction buffers used. Arrows represent
the presence of cleavage products. Thick and thin arrows indicate cleavage with a pyrimidine-specific chemical (Os or Hy) and a purine-specific
chemical (DEPC), respectively. As seen in A, the (GAA)240 repeat was cleaved with both osmium tetroxide and DEPC (seen as a smear), indicating
that both the GAA and TTC strands are unpaired or altered in conformation (non–B DNA). The (GAA)9 repeat similarly shows cleavage with
osmium tetroxide (A–C and E), DEPC (A and D), and hydroxylamine (B), indicating that the normal (non-FRDA) GAA triplet-repeat length
also adopts an unusual DNA structure. Notably, the pyrimidine-specific chemical (C) and the purine-specific chemical (D) do not react with
bases on opposite strands. Hydroxylamine (at pH 6) and osmium tetroxide (at pH 7–8) produce identical cleavage products (B and E). DEPC
reacts with the purine strand of the GAA repeat and with an A-rich sequence element situated ∼150 bp downstream of the GAA repeat (A and
F; see text). The results of the various chemical probings are summarized in F. The GAA repeat (blackened box) is shown within the region of
the X25 intron 1 analyzed (horizontal line). The positions of the unique BamHI and SmaI restriction sites are indicated. Thick and thin arrows
are used to indicate pyrimidine- and purine-specific cleavages, respectively. The smaller thin arrow indicates the cleavage at the A-rich sequence
located downstream of the GAA repeat and the SmaI site. The positions of the arrows within the GAA repeat are arbitrary and do not reflect
sublocalization to either the center or either end of the repeat tract (see text).
and eukaryotic systems, and that the GAA trinucleotide
repeat adopts an unusual DNA structure. In the course
of the probing of the GAA repeat sequence, an A-rich
sequence element was discovered, in the vicinity of the
GAA repeat, that also adopts an unusual structure in
vitro. In addition to the expanded GAA repeats, the
unusual DNA structure was also detected in normal re-
peat-bearing alleles, which are apparently transcribed
normally. Our hypothesis is that the unusual DNA struc-
ture formed by the expanded allele is likely to be more
stable—and that it would thus pose a more formidable
block to transcription.
We have determined, using both prokaryotic and eu-
karyotic RNA polymerases in vitro, that the threshold
for the transcriptional deficiency is !79 GAA repeats.
Because of the inherent instability and recombinogenic
nature of the GAA triplet repeat within plasmids in E.
coli, the largest stable repeat cloned consisted of 100
GAA triplets. However, the (GAA)79 and (GAA)100 repeat
alleles used in our transcription experiments are both
larger than the smallest expansion associated with
FRDA (i.e., GAA66). Using a series of cloned repeats, we
have successfully demonstrated the biologically signifi-
cant negative correlation between increase in GAA re-
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Figure 4 Possible non–B DNA structures adopted by the pur•pyr tract, resulting from the GAA repeat sequence. Although FRDA alleles
may possess hundreds of GAA triplets, only 13 or 17 repeats are shown in these models, for the sake of simplicity. A, Pur•pyr tract, shown as
a linear duplex with normal Watson-Crick base pairing indicated (vertical bars). B, Intramolecular pur-pur•pyr triplex, which could result if
the 5′ or 3′ half of the purine-rich strand dissociates from its complementary duplex strand and intercalates in an antiparallel orientation, in
the major groove of the 3′ or 5′ half of the pur•pyr tract, by reverse Hoogsteen pairing (•). These are the so-called r5 (left) and r3 (right)
configurations, respectively. Although pyr-pur•pyr intramolecular triplex (i.e., H DNA) formation is also theoretically possible, this does not
form at physiological pH and in the presence of divalent cations and therefore has not been considered. C, Pur-pur•pyr intramolecular triplex,
after formation of the GAA-containing X25 pre-mRNA (unbroken line). This could pair with the single-stranded half of the homopyrimidine
strand via Watson-Crick bonds (vertical bars), further stabilizing the triplex structure. These triplex models are compatible with physiological
conditions and could theoretically form in vivo.
peat length and accumulation of full-length transcript.
This length dependency is consistent with (a) the obser-
vation of a milder deficiency of X25 mRNA in lympho-
blasts isolated from a patient with a smaller-than-av-
erage expansion and, more significantly, (b) the inverse
correlation between age at onset and GAA repeat length
(Du¨rr et al. 1996; Filla et al. 1996; Montermini et al.
1997b). The deficiency of in vitro transcription seen in
our heterologous system implies that the reduction of
X25 mRNA in FRDA is likely to be transcriptional
rather than posttranscriptional. The length-dependent
deficiency further implies an acquisition of additional
stability by longer GAA sequences, possibly via some
higher-order structure. Although we have only compared
transcription of GAA repeats with TTC repeats of sim-
ilar length, it would be interesting to also generate com-
parative data with other similarly expanded sequences.
Why is the transcriptional block apparent or more
severe when synthesis of GAA-rich transcript is at-
tempted? A similar observation has also been made by
Grabczyk and Fishman (1995), who coined the term
“transcriptional diode” to describe the unidirectional
transcriptional blockade observed with a 0.5-kb se-
quence containing three interspersed pur•pyr tracts, im-
mediately upstream of the rat GAP-43 gene. Pur•pyr
sequences form triplexes in supercoiled DNA (Frank-
Kamenetskii and Mirkin 1995), structures that can ef-
ficiently block transcriptional elongation (Escude et al.
1996; Giovannangeli et al. 1996). Given that transcrip-
tion itself induces a local wave of negative supercoiling
behind the polymerase (Wu et al. 1988), Grabczyk and
Fishman (1995) speculated that a transcription-induced
triplex was being formed. The unidirectionality was at-
tributed to the differential stabilities, at physiological
pH, of the pur-pur•pyr triplex, predicted to form when
the purine-rich strand is transcribed, versus the pyr-
pur•pyr triplex, in the opposite direction (Frank-Ka-
menetskii and Mirkin 1995). Our observation that the
GAA repeat already maintains an unusual DNA struc-
ture prior to transcription would argue against this hy-
pothesis. However, it is possible that transcription may
serve to further stabilize the already altered DNA struc-
ture or perhaps even induce a novel structure.
The newly synthesized transcript could also help ex-
plain the function of the GAA repeat as a transcriptional
diode. If it is assumed that the GAA repeat (fig. 4A)
forms a pur-pur•pyr intramolecular DNA triplex (fig.
4B), which is known to be stable at physiological pH,
the newly synthesized GAA-rich mRNA (as seen in vivo)
could form a hybrid RNA-DNA duplex with the re-
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sulting free TTC single strand (fig. 4C), further stabiliz-
ing the unusual DNA structure (Reaban and Griffin
1990, 1991; Stavnezer 1991). On the other hand, tran-
scription of the TTC strand would not be able to serve
this function, since the analogous situation would re-
quire the formation of a pyr-pur•pyr triplex, unlikely to
form at physiological pH and divalent cationic concen-
tration (used in our experiments). This would appear to
be the most likely mechanism; however, the possibility
that the unusual DNA structure is not a triplex cannot
be totally disregarded.
Ohshima et al. (1996a) have predicted another sce-
nario, whereby the GAA-rich X25 mRNA forms an an-
tiparallel (pur-pur•pyr) intermolecular RNA-DNA•DNA
triplex (formed via A-A•T and G-G•C triplets). This
would also explain the unidirectional block to transcrip-
tion, since the parallel counterpart would be unstable at
physiological pH and cationic concentration (Frank-Ka-
menetskii and Mirkin 1995). However, this model may
be unlikely, for the following reasons. First, systematic
analyses have shown that, in dramatic contrast to the
ability of RNA to be involved in pyr-pur•pyr triplexes,
a stable pur-pur•pyr triplex could not form with RNA
in any of the three strands (Skoog and Maher 1993;
Semerad and Maher 1994). Second, using electrophor-
etic-mobility-shift assays (EMSA), we were unable to
demonstrate the formation of parallel or antiparallel in-
termolecular DNA triplexes, using a cloned (GAA)11 re-
peat sequence (at pH 7.4 in the presence of 10 mM
MgCl2; authors’ unpublished results). This appears to
be a peculiarity of the GAA triplet repeat per se, since
we could readily demonstrate antiparallel triplex for-
mation with four other random pur•pyr sequences of
similar length that were from the promoter regions of
the PMP22 gene, using EMSAs and footprinting anal-
yses (S. I. Bidichandani and P. I. Patel, unpublished
results).
Our chemical probing experiments demonstrated the
presence of an unusual DNA structure in linear DNA
molecules. There seems to be a sharp divide in the lit-
erature regarding the role of superhelicity in the etiology
of non–B DNA structures adopted by pur•pyr sequences.
Although some investigators have certainly shown that
linear molecules containing pur•pyr sequences adopt
such structures (Hentschel 1982; Htun et al. 1984; Evans
and Efstratiadis 1986; McCarthy and Heywood 1987),
others have maintained that supercoiling is a prerequisite
(Hanvey et al. 1988; Kohwi and Kohwi-Shigematsu
1988; Voloshin et al. 1988; Bernue´s et al. 1989). They
have used widely varying parameters, differing in
pur•pyr sequence composition and length, pH, and ionic
conditions, and have used chemical or enzymatic probes.
Evans and Efstratiadis (1986) showed a positive corre-
lation between cleavage of a linear pur•pyr sequence and
increasing length, with (GA)38 being clearly more reac-
tive than (GA)20 or (GA)10. A similar positive correlation
was also seen with lower monovalent cationic concen-
trations. Htun and Dahlberg (1989) showed that DNAs
that are relaxed or that show low negative supercoiling
form a different triplex conformer, compared to what
occurs when negative supercoiling is moderately high.
Another fundamental difference between the molecules
used in our experiments and those used by others is that
we have a considerable length of natural X25 intron 1
sequence flanking the GAA repeat. Both the composition
(Kang et al. 1992) and length (Evans and Efstratiadis
1986) of flanking sequences have been shown to play
significant roles in the kinetics of non–B DNA structure
formation. Modest alterations mediated by restriction
digestion did not alter the cleavage pattern in our
experiments.
The 38-bp A-rich sequence (79% A; 100% A/T) sit-
uated ∼150 bp downstream of the GAA repeat (on the
GAA strand) was also found to be hyperreactive to
DEPC treatment. This sequence represents the 3′ end of
the right monomer unit of the Alu repeat within which
the GAA repeat is located. Most Alu elements end in a
10–48 bp A-rich sequence often interrupted by sporadic
C’s and G’s (Kariya et al. 1987), and so this 38-bp A/
T sequence may be somewhat unique. The reactivity of
this sequence is analogous to that seen at the A/T-rich
sequence situated immediately downstream of the
chicken embryonic myosin heavy-chain gene (McCarthy
and Heywood 1987). This latter sequence was sensitive
to S1 nuclease at pH 4.5 and 7.5, in both supercoiled
and linear plasmid DNA. These structures may also be
related to the open helical structure adopted by the TAA
triplet repeat, although this was not detected in linear
DNA molecules or at physiological magnesium concen-
trations (Ohshima et al. 1996b). The significance of any
structure adopted by the 38-bp A-rich sequence is pres-
ently unknown. This sequence is not likely to play a
significant role in the inhibition of transcription, since
pure GAA repeats (without any flanking intron 1 se-
quence) have previously, in the early stages of this project
(Bidichandani et al. 1996), been found to display the
same unidirectional transcriptional blockade. Further-
more, we have determined that this A/T-rich sequence
is polymorphic, with a deletion of (TAA)2 within the
(TAA)4 tract close to its 5
′ end. This was seen in 3 of
36 normal chromosomes and in 0 of 20 expanded chro-
mosomes. This polymorphism was also independently
observed by Montermini et al. (1997a).
The causal relationship between the unusual DNA
structure and the transcriptional deficiency remains to
be formally proved. With all the data taken together, it
would be expected that the stable unusual DNA struc-
ture arising from larger GAA expansions would interfere
with transcriptional elongation. Triplexes are known to
effectively block transcriptional elongation (Escude et al.
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1996; Giovannangeli et al. 1996). However, the absence
of any truncated products in our gels leaves open the
possibility that there may be direct or indirect interfer-
ence with transcriptional initiation. Situated within the
first intron of X25, the expansion could directly influ-
ence the assembly of the eukaryotic transcriptional ma-
chinery. On the other hand, several genes are known to
contain transcriptional enhancers within their first in-
trons. The GAA triplet repeat maps within an Alu repeat
element, and there is growing evidence indicating tran-
scriptional regulatory roles for such sequences, within
several genes (Britten 1996). It is possible that the Alu
repeat containing the normal polymorphic GAA triplet
repeat serves as an enhancer, which is disrupted by the
expansion seen in FRDA alleles. However, this possi-
bility has been tentatively ruled out by testing this seg-
ment for enhancer activity in transient-transfection ex-
periments using a mammalian fibroblast cell line
(authors’ unpublished data).
Our findings raise the possibility that the GAA triplet
repeat in the X25 gene (and, by inference, also in other
genomic locations) may adopt non–B DNA structures
in vivo. Although it remains to be proved, this epige-
netic modification could be the ultimate molecular basis
of FRDA. If so, altering the stability of such a structure
could help alleviate the transcriptional block and serve
as a potential therapeutic strategy for FRDA. Moreover,
the naturally occurring spectrum of GAA repeat–bearing
alleles seen in FRDA chromosomes could serve as a val-
uable resource for studying the effect of pur•pyr se-
quences on DNA structure, recombination, and repli-
cation in vivo.
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